By now, most people are aware of the weight-loss successes attributed to medications like Ozempic, Wegovy, Mounjaro, and Zepbound. These drugs, known as GLP-1 receptor agonists, have gained popularity for their effectiveness in aiding weight loss. However, these drugs have been used since 2017 primarily for diabetes treatment, and ongoing research is examining their broader applications.
Researchers are exploring GLP-1’s potential benefits in various health areas, including mental health, longevity, cancer, and more. These investigations are vital as they may reveal new opportunities for tackling complex health issues.
Three writers have shared insights into intriguing side effects of GLP-1 drugs that merit attention.
Prepare for an Early Influenza Season: Vaccination Timing Is Crucial 
FDA Issues Highest Risk Warning for Recalled Salad Products 
Essential Preparations for Cold and Flu Season 
Eli Lilly’s Retatrutide and Its Impact on Weight Loss and Health 
FDA’s Abortion Pill Review Raises Concerns Among GOP Lawmakers 
Kai Trump Undergoes Successful Wrist Surgery